Neil William Aubuchon - 10 Mar 2026 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
10 Mar 2026
Net transactions value
+$149,912
Form type
4
Filing time
10 Mar 2026, 18:20:39 UTC
Previous filing
26 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aubuchon Neil William Chief Commercial Officer 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO /s/ Michael Morneau, as Attorney-in-Fact 10 Mar 2026 0002106781

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Purchase $149,912 +4,475 $33.50 4,475 10 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.